Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
64.93
+1.08 (1.69%)
At close: Apr 23, 2024, 4:00 PM
65.00
+0.07 (0.11%)
After-hours: Apr 23, 2024, 4:59 PM EDT

Viking Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-85.9-68.87-54.99-39.5-25.78-22.06-20.58-14.73-23.4-21.88
Upgrade
Depreciation & Amortization
0.290.290.30.280.2600000
Upgrade
Share-Based Compensation
16.758.676.15.823.742.611.451.792.60.01
Upgrade
Other Operating Activities
-4.5211.511.0111.62-2.980.74.371.8712.0720.29
Upgrade
Operating Cash Flow
-73.38-48.4-47.59-21.78-24.75-18.76-14.76-11.07-8.73-1.59
Upgrade
Change in Investments
-179.0954.7537.9641.577.46-265.73-1.733.03-13.470
Upgrade
Investing Cash Flow
-179.0954.7537.9641.577.46-265.73-1.733.03-13.470
Upgrade
Share Issuance / Repurchase
278.55.77.591.271.113052311.5725.42-0
Upgrade
Debt Issued / Paid
00000-3.83-0.08-0.0902.5
Upgrade
Other Financing Activities
-7.12-1.53-0.71-0.32-0.22-0.89-0.52-1.13-3.2-0.33
Upgrade
Financing Cash Flow
271.384.166.880.950.89300.2822.410.3522.212.17
Upgrade
Exchange Rate Effect
-0.03-0.2600000000
Upgrade
Net Cash Flow
18.9110.52-2.7520.74-16.415.795.912.310.010.58
Upgrade
Free Cash Flow
-73.38-48.4-47.59-21.78-24.75-18.76-14.76-11.07-8.73-1.59
Upgrade
Free Cash Flow Per Share
-0.78-0.63-0.62-0.30-0.34-0.33-0.57-0.68-1.37-0.38
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).